@LiverForum

Advancing regulatory science for NAFLD/NASH by providing independent and neutral venue for ongoing multi-stakeholder dialogue.

 Washington, DC
forumresearch.org/liver-forum
Joined December 2017
  • Tweets228
  • Following185
  • Followers830
22Media
Our latest, 'Attribution of NASH as Etiology of Cirrhosis for Clinical Trials Eligibility' in latest issue of @AGA_Gastro - 👏👏👏 congratulations to authors and all working group members! authors.elsevier.com/c/1bbMP…
5
New Positions Open! forumresearch.org/aboutconta…
259
New Positions Open! https://forumresearch.org/aboutcontact/employment-and-internship-opportunities

ALT New Positions Open! https://forumresearch.org/aboutcontact/employment-and-internship-opportunities

190
October is Liver Awareness Month. Join us TODAY starting at 3:45 pm ET as FLF joins @MadrigalPharma to ring the @Nasdaq closing bell to increase awareness of the need for more screening & testing to improve diagnosis & staging of #NAFLD #NASH→bit.ly/3uMpRiX #LiverHealth
1
13
1
24
The Liver Forum retweeted
Wayne Eskridge
@WayneEskridge17 Sep 2021
ELF was just approved as a blood test for fibrosis by @US_FDA and this is an important step in the efforts to develop better tools for diagnosing advanced liver disease and getting away from liver biopsy➡️bit.ly/3yULq1f #NAFLD #NASH #liverhealth #patientadvocacy #blog
2
16
5
45
ELF by @Siemens has been approved by the FDA as a prognostic maker to be used in #NASH. #livertwitter 👇🏼@AlkhouriNaim @schattenbergJ @KathleenCoreyMD @DrLoomba @DrMTLong @RomaLevy @NASH_and_coffee @AASLDtweets @drmoutaz @HD3vedi @surfing_NASH
Scott Isaacs
@scottisaacsmd25 Aug 2021
The #ELF (Enhanced Liver Fibrosis) Test has been approved by the FDA as a prognostic marker in patients with #NASH to assess the likelihood of progression to #cirrhosis and liver-related clinical events. businesswire.com/news/home/2…

FDA Grants Marketing Authorization to Siemens Healthineers ELF Test for NASH Prognostic Assessment

Siemens Healthineers announced today that its Enhanced Liver Fibrosis (ELF™) Test was granted marketing authorization under the De Novo review pathway.1 The ...

businesswire.com
1
5
24
Ani Kardashian on food insecurity & assoc w/all-cause mortality in US adults w/ #NAFLD #ILC2021: food insecurity is ltd or uncertain availability of nutritionally adequate foods or inability to acquire foods in socially acceptable way. 35 million (18 million in USA) experience it
1
3
4
Replying to @LancetGastroHep @AniKardashianMD
Food insecurity in adults with NAFLD associated with all-cause mortality after adjustment for a number of factors #ILC2021
8
2
13
The Liver Forum retweeted
Echosens@Echosens24 Jun 2021
Join us today at #ILC2021 for a live webinar with Prof. Boursier and Prof. Noureddin on #FibroScan-based Scores: Agile 3+, Agile 4, Fast™, to identify early and accurately patients at risk of developing cirrhosis and liver-related complications. bit.ly/3gTRHn5 #NAFLD
2
3
June 10th is International #NASHDay. Join advocates & partners from across the🌐as we spread awareness about this serious #liverdisease that is on the rise. Together we can make our voices heard! Join the conversation🙌#NASHDay⮕bit.ly/3xpNaPV #NAFLD #NASH @GlobalLiver
13
1
31
The Liver Forum retweeted
Wayne Eskridge
@WayneEskridge17 May 2021
I don't know that this is news really but I was one of the patient advocates interviewed for an extensive article in @PharmaVOICE about the need for industry to include patients in the process of drug development⮕bit.ly/3h5wWq5 #NASH #NAFLD #PatientAdvocacy
6
13
Nonalcoholic fatty liver disease (#NAFLD) is the most common #ChronicLiverDisease (#CLD) in children worldwide. Our very own Dr. Veronica Miller & the @LiverForum Pediatric Working Group explore research for a “silver bullet” treatment. bit.ly/3tH4P3j
3
1
A new paper from BPH's Dr. Veronica Miller & the @LiverForum Pediatric Working Group combs through the research for a “silver bullet” treatment for nonalcoholic fatty liver disease (#NAFLD), the most common #ChronicLiverDisease in children worldwide. publichealth.berkeley.edu/ne…

Looking for a silver bullet to treat children’s nonalcoholic fatty liver disease

publichealth.berkeley.edu
1
The Liver Forum retweeted
EASLnews
@EASLnews4 Feb 2021
Today is #WorldCancerDay, 4 Feb. Did you know? #Livercancer is the 3rd-leading cause of cancer-related deaths🌐worldwide. What are the main causes of liver cancer? ➡️bit.ly/LC-infographic To find out more, consult our new infographic, Liver Cancer Explained. @EASLedu
3
22
39
INDUSTRY STAKEHOLDERS: Get email updates from the CDER Small Business and Industry Assistance (SBIA) program to learn about: 🟠 Industry news 🟠 New guidances 🟠 Meetings & conferences 🟠 Educational tutorials 🟠 Webinars 🟠 And more! Sign up here: ow.ly/fq0R50D1AnG
2
1
2
The Translational Science Interagency Fellowship sponsored by FDA & @ncats_nih_gov is looking for individuals interested in bringing safe & effective drugs, regimens, and devices from the bench to the bedside as quickly as possible. Apply now: go.usa.gov/x7kFj
2
6
8
We are hiring! Know anyone with a background in project management, research, & liver disease? Share our job announcement: bit.ly/3pfAaIy
2
3
Don't miss this #webcast on January 29th as the @US_FDA will provide a summary of the agency's current thinking on the published draft guidance📄 & regulatory pathways for development of drugs for treatment of #NASH👉bit.ly/38c7GIt
5
11
Learn about FDA’s table of surrogate endpoints that provides transparency, coherency, and consistency for stakeholders seeking to design effective drug development programs in the latest #CDERImpactStory: go.usa.gov/xAan9
4
1
11
The Liver Forum retweeted
EASLnews
@EASLnews10 Dec 2020
Today we’re launching the International Liver Congress™ 2021 easl.eu/ilc2021 Clear your agendas for Wed to Sat, 23–26 June. Prepare to send in your abstracts & register for #EASL’s flagship #ILC2021 on beating liver disease together. Share this with your peers! @EASLedu
1
23
2
37
DATES HAVE CHANGED! Register for #NASHTAG 2021 today. nash-tag.org/
2
2
Load more